CrossBeta Biosciences Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $10.4M

  • Investors
  • 1

CrossBeta Biosciences General Information

Description

Developer of drug discovery and development platforms designed to generate stable oligomers. The company's platforms offer the discovery and development of multiple misfolded protein diseases, disease-specific antibodies, biomarker assays, and oral treatment of Alzheimer's disease, thereby enabling patients to avail quality drugs to recover from chronic diseases.

Contact Information

Website
www.crossbeta.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • PO Box 13283
  • 3507 LG Utrecht
  • Netherlands
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
ImmunoPrecise Antibodies
Vertical(s)
Life Sciences
Corporate Office
  • PO Box 13283
  • 3507 LG Utrecht
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CrossBeta Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 30-Jan-2018 $10.4M Completed Generating Revenue
5. Grant 18-Apr-2016 Completed Generating Revenue
4. Later Stage VC 03-Mar-2013 Completed Generating Revenue
3. Grant 28-Aug-2011 Completed Generating Revenue
2. Early Stage VC 12-Apr-2010 $2.7M $2.7M Completed Startup
1. University Spin-Out 01-Jan-2005 Completed Startup
To view CrossBeta Biosciences’s complete valuation and funding history, request access »

CrossBeta Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of drug discovery and development platforms designed to generate stable oligomers. The company's platforms off
Biotechnology
Utrecht, Netherlands
3 As of 2023

Gaithersburg, MD
 

New Haven, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CrossBeta Biosciences Competitors (45)

One of CrossBeta Biosciences’s 45 competitors is NexImmune, a Formerly VC-backed company based in Gaithersburg, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD
Arvinas Formerly VC-backed New Haven, CT
Verge Genomics Venture Capital-Backed South San Francisco, CA
SiteOne Therapeutics Venture Capital-Backed San Francisco, CA
Cullgen Venture Capital-Backed San Diego, CA
You’re viewing 5 of 45 competitors. Get the full list »

CrossBeta Biosciences Patents

  • 84

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

CrossBeta Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2365825-A1 Cross-beta structures as carriers in vaccines Inactive 18-Nov-2008
US-20110287047-A1 Cross-beta structures as carrier in vaccines Inactive 18-Nov-2008
CA-2705242-A1 Enhancement of immunogenicity of antigens Inactive 08-Nov-2007
AU-2008325359-A1 Enhancement of immunogenicity of antigens Inactive 08-Nov-2007
US-20090142377-A1 Immunogenic compositions Inactive 08-Nov-2007 A61K39/145
To view CrossBeta Biosciences’s complete patent history, request access »

CrossBeta Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CrossBeta Biosciences Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
EuroTransBio Government
Michael J. Fox Foundation Limited Partner
Rijksdienst voor Ondernemend Nederland Government Minority
SenterNovem Corporation Minority
Utrecht Holdings Not-For-Profit Venture Capital Minority
To view CrossBeta Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial

CrossBeta Biosciences FAQs

  • When was CrossBeta Biosciences founded?

    CrossBeta Biosciences was founded in 2005.

  • Where is CrossBeta Biosciences headquartered?

    CrossBeta Biosciences is headquartered in Utrecht, Netherlands.

  • What is the size of CrossBeta Biosciences?

    CrossBeta Biosciences has 3 total employees.

  • What industry is CrossBeta Biosciences in?

    CrossBeta Biosciences’s primary industry is Biotechnology.

  • Is CrossBeta Biosciences a private or public company?

    CrossBeta Biosciences is a Private company.

  • What is the current valuation of CrossBeta Biosciences?

    The current valuation of CrossBeta Biosciences is .

  • What is CrossBeta Biosciences’s current revenue?

    The current revenue for CrossBeta Biosciences is .

  • How much funding has CrossBeta Biosciences raised over time?

    CrossBeta Biosciences has raised $2.7M.

  • Who are CrossBeta Biosciences’s investors?

    EuroTransBio, Michael J. Fox Foundation, Rijksdienst voor Ondernemend Nederland, SenterNovem, and Utrecht Holdings have invested in CrossBeta Biosciences.

  • Who are CrossBeta Biosciences’s competitors?

    NexImmune, Arvinas, Verge Genomics, SiteOne Therapeutics, and Cullgen are some of the 45 competitors of CrossBeta Biosciences.

  • When was CrossBeta Biosciences acquired?

    CrossBeta Biosciences was acquired on 30-Jan-2018.

  • Who acquired CrossBeta Biosciences?

    CrossBeta Biosciences was acquired by ImmunoPrecise Antibodies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »